Camlin Fine Sciences Adjusts Evaluation Score Amid Strong Financial Performance and Challenges

Jul 08 2025 08:07 AM IST
share
Share Via
Camlin Fine Sciences has recently adjusted its evaluation score, reflecting a shift in technical trends. The company reported a PAT of Rs 17.67 crore, a 43.42% growth, and record net sales of Rs 437.46 crore. However, challenges remain with a modest ROCE and high Debt to EBITDA ratio.
Camlin Fine Sciences, a midcap player in the specialty chemicals industry, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a mildly bullish stance to a bullish outlook.

In terms of key financial metrics, the company reported a significant PAT of Rs 17.67 crore for the latest six months, showcasing a growth rate of 43.42%. Additionally, net sales reached a record high of Rs 437.46 crore, indicating robust operational performance. The operating profit to interest ratio stood at 3.69 times, further emphasizing the company's financial health in the recent quarter.

Despite these positive indicators, Camlin Fine Sciences faces challenges in long-term fundamental strength, with an average Return on Capital Employed (ROCE) of 7.97%. The company has also experienced modest growth in net sales and operating profit over the past five years, at annual rates of 9.97% and 1.65%, respectively. Furthermore, a high Debt to EBITDA ratio of 3.39 times raises concerns about its ability to service debt.

Overall, while the stock has demonstrated impressive returns, outperforming the BSE500 over various time frames, the underlying financial metrics suggest a complex landscape for Camlin Fine Sciences.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News